Viking Therapeutics (VKTX) Net Shares Issued and Repurchased (2014)

Viking Therapeutics (VKTX) reported Net Shares Issued and Repurchased of -$2498.0 for Q3 2014.

Viking Therapeutics (VKTX) Net Shares Issued and Repurchased (2014) Analysis & Trends

Viking Therapeutics (VKTX) has 1 years of Net Shares Issued and Repurchased data on file, last reported at -$2498.0 in Q3 2014.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued (Qtr)
1 Oculis Holding AG 66,681.27 Bn 66,680.98 Bn - -
2 Nanobiotix 1,905.61 Bn 1,905.55 Bn - -
3 Akari Therapeutics 1,011.81 Bn 1,011.81 Bn - -
4 BeOne Medicines 467.29 Bn 462.50 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 122.89 Bn 115.65 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 70.28 Bn 61.53 Bn 3.31 Bn -
7 Belite Bio 62.93 Bn 62.93 Bn - -
8 Argenx Se 55.90 Bn 50.72 Bn 1.41 Bn -
9 Alnylam Pharmaceuticals 37.64 Bn 34.63 Bn 959.66 Mn -
10 Viking Therapeutics 4.01 Bn 4.01 Bn - -

Historic Data

Download Data
DateValue
Sep 30, 2014 -2,498.00
Sep 30, 2014 -2,498.00